Tech Company Financing Transactions

Cognito Therapeutics Funding Round

Cognito Therapeutics closed a $73 million Series B investment round on 3/22/2023. Backers included FoundersX Ventures, Alzheimer's Drug Discovery Foundation and IAG Capital Partners.

Transaction Overview

Announced On
3/22/2023
Transaction Type
Venture Equity
Amount
$73,000,000
Round
Series B
Proceeds Purpose
The company intends to use the funds to advance pivotal study of its non-invasive neuromodulation device, which delivers proprietary gamma frequency light and sound stimulation intended to treat Alzheimer's Disease. In a prior Phase 2 clinical trial, the device demonstrated a significant slowing in functional and cognitive decline in the treatment group, as well as a significant decline in brain atrophy over a six-month period. To further demonstrate the efficacy of the device, Cognito is currently enrolling patients in its pivotal clinical trial HOPE for Alzheimer's Disease, across approximately 50 clinical centers in the United States with a target enrollment of 500 patients.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1218 Massachusetts Ave 200
Cambridge, MA 02138
USA
Email Address
Overview
Cognito Therapeutics is advancing the field of neuromodulation to create novel therapeutics that improve the lives of patients living with neurodegenerative diseases.
Profile
Cognito Therapeutics LinkedIn Company Profile
Social Media
Cognito Therapeutics Company Twitter Account
Company News
Cognito Therapeutics News
Facebook
Cognito Therapeutics on Facebook
YouTube
Cognito Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Brent Vaughan
  Brent Vaughan LinkedIn Profile  Brent Vaughan Twitter Account  Brent Vaughan News  Brent Vaughan on Facebook
Chief Medical Officer
Tom Megerian
  Tom Megerian LinkedIn Profile  Tom Megerian Twitter Account  Tom Megerian News  Tom Megerian on Facebook
Chief Scientific Officer
Mihaly Hajos
  Mihaly Hajos LinkedIn Profile  Mihaly Hajos Twitter Account  Mihaly Hajos News  Mihaly Hajos on Facebook
President
Zach Malchano
  Zach Malchano LinkedIn Profile  Zach Malchano Twitter Account  Zach Malchano News  Zach Malchano on Facebook
Vice President
Divya Cohen
  Divya Cohen LinkedIn Profile  Divya Cohen Twitter Account  Divya Cohen News  Divya Cohen on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/22/2023: Piclo venture capital transaction
Next: 3/22/2023: RiseKit venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary